Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
774 Pancreatic Cancer
clinical trials

Oncology Clinical Trial
FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Rhode Island Hospital and The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
Status: Enrolling, Phase II
Updated: 3/28/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 8/31/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers
Status: Enrolling, Phase I
Updated: 8/3/2016
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
Status: Enrolling
Updated: 2/29/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Henry Joyce Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Georgetown University
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
The START Center for Cancer Care
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
Community Healthcare System
mi
from
Munster, IN
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Hematology Oncology Associates of Treasure Coast
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Status: Enrolling, Phase I
Updated: 3/14/2018
MSKCC
mi
from
New York, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling, Phase
Updated: 4/18/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling, Phase
Updated: 4/18/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
Status: Enrolling, Phase I
Updated: 2/9/2016
Washington University School of Medicine
mi
from
St Louis, MO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Preoperative Pilot Study to Assess Safety and Immunological Effect of Pembrolizumab (Keytruda®) in Combination With Paricalcitol With or Without Chemotherapy in Patients With Resectable Pancreatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Coast Medical Oncology Corporation
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Louis Cancer Care
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Joseph Heritage Healthcare
mi
from
Fullerton, CA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology-Midland Allison Cancer Center
mi
from
Midland, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Medical Group
mi
from
Morristown, NJ
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Hartford Healthcare Cancer Institute @ Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Status: Enrolling, Phase II
Updated: 12/31/1969
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Georgetown University Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Washington/Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Status: Enrolling, Phase III
Updated: 12/31/1969
Gundersen Lutheran Medical Foundation, Inc
mi
from
La Crosse, WI
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer
Status: Enrolling, Phase I
Updated: 10/27/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Oncology Clinical Trial
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Status: Enrolling, Phase I
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/8/2017
The Johns Hopkins SKCCC
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ASN007 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
CAB-AXL-ADC Safety and Efficacy Study in Patients With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Ellis Fischel Cancer Center, University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
CPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
CPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Micoenvironment in Resectable Pancreatic Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Pancreatic Cancer
Status: Enrolling, Phase
Updated: 4/3/2018
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois Cancer Specialists
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
North Shore Hematology Oncology
mi
from
East Setauket, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ucla
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Niraparib in Patients With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Virginia Cancer Specialist
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Enrolling, Phase I, II
Updated: 12/31/1969
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Newton-Wellesley Hospital
mi
from
Newton, MA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kansas Cancer Center - Clinical Research Center
mi
from
Fairway, KS
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kansas Cancer Center - North
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
PMG Research of Hickory, LLC
mi
from
Hickory, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
FirstHealth Moore Regional Hospital
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
California Cancer Associates for Research Excellence (cCARE)
mi
from
Encinitas, CA
Click here to add this to my saved trials
Oncology Clinical Trial
HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery
Status: Enrolling, Phase IV
Updated: 12/31/1969
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
QUILT-3.017: Study of NEO-201 in Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Florida Pancreas Collaborative Next Generation Biobank
Status: Enrolling, Phase
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Regional Cancer Care Associates
mi
from
Howell, NJ
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Hematology Oncology of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Arena Oncology Associates PC
mi
from
Lake Success, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Central Pennsylvania Hematology and Medical Oncology Assoc
mi
from
Lemoyne, PA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Southeast Nebraska Hematology & Oncology Consultants
mi
from
Lincoln, NE
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Northwest Alabama Cancer Center, PC
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Morton Coleman, MD
mi
from
New York, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
Norwalk Hospital
mi
from
Norwalk, CT
Click here to add this to my saved trials
1 2 3 4 5 6 7 8